Paychex Inc: Form 10-K for the period ended May 31, 2024
Filed with the SEC on Jul 11, 2024 and accepted by EDGAR at Jul 11, 2024, 16:03 ET.
Sections
The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-05-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2023-06-01 to 2024-05-31 | $5.13bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2023-06-01 to 2024-05-31 | $1.48bn | us-gaap:CostOfRevenue |
| Selling, general and administrative | 12 months2023-06-01 to 2024-05-31 | $1.62bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2023-06-01 to 2024-05-31 | $2.17bn | us-gaap:OperatingIncomeLoss |
| Interest expense | 12 months2023-06-01 to 2024-05-31 | $37.3m | us-gaap:InterestExpense |
| Income tax | 12 months2023-06-01 to 2024-05-31 | $527.6m | us-gaap:IncomeTaxExpenseBenefit |
| Diluted EPS | 12 months2023-06-01 to 2024-05-31 | $4.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2023-06-01 to 2024-05-31 | $4.69 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2023-06-01 to 2024-05-31 | 362,100,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2023-06-01 to 2024-05-31 | $1.90bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2023-06-01 to 2024-05-31 | $161.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 12 months2023-06-01 to 2024-05-31 | $1.32bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2023-06-01 to 2024-05-31 | $169.2m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-05-31 | $1.47bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-05-31 | $7.25bn | us-gaap:AssetsCurrent |
| Total assets | At period end2024-05-31 | $10.38bn | us-gaap:Assets |
| Current liabilities | At period end2024-05-31 | $5.31bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-05-31 | $6.58bn | us-gaap:Liabilities |
| Long-term debt | At period end2024-05-31 | $798.6m | us-gaap:LongTermDebtNoncurrent |
| Short-term borrowings | At period end2024-05-31 | $18.7m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2024-05-31 | $3.80bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0000950170-24-082958. Last ingested by Listed: Oct 27, 2026, 16:32 ET. Listed shows no prices and gives no investment advice.